Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1971 2
1972 4
1973 2
1974 1
1975 2
1976 4
1977 2
1978 2
1979 4
1980 2
1981 2
1982 6
1985 4
1986 1
1987 1
1990 3
1992 1
1993 1
1996 1
1999 2
2001 3
2003 1
2006 2
2007 1
2008 1
2010 1
2011 1
2012 2
2013 1
2015 1
2017 1
2018 2
2019 1
2020 4
2021 5
2022 2
2023 1
2024 4
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.
Mayer-Hamblett N, Ratjen F, Russell R, Donaldson SH, Riekert KA, Sawicki GS, Odem-Davis K, Young JK, Rosenbluth D, Taylor-Cousar JL, Goss CH, Retsch-Bogart G, Clancy JP, Genatossio A, O'Sullivan BP, Berlinski A, Millard SL, Omlor G, Wyatt CA, Moffett K, Nichols DP, Gifford AH; SIMPLIFY Study Group. Mayer-Hamblett N, et al. Lancet Respir Med. 2023 Apr;11(4):329-340. doi: 10.1016/S2213-2600(22)00434-9. Epub 2022 Nov 4. Lancet Respir Med. 2023. PMID: 36343646 Free PMC article. Clinical Trial.
Allopurinol-mercaptopurine interaction.
Weissman AM, Christian DG, Cornelis WA, Fortner CL. Weissman AM, et al. Among authors: fortner cl. J Am Pharm Assoc. 1973 Jan;13(1):2. J Am Pharm Assoc. 1973. PMID: 4682571 No abstract available.
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.
Keating C, Yonker LM, Vermeulen F, Prais D, Linnemann RW, Trimble A, Kotsimbos T, Mermis J, Braun AT, O'Carroll M, Sutharsan S, Ramsey B, Mall MA, Taylor-Cousar JL, McKone EF, Tullis E, Floreth T, Michelson P, Sosnay PR, Nair N, Zahigian R, Martin H, Ahluwalia N, Lam A, Horsley A; VX20-121-102 Study Group; VX20-121-103 Study Group. Keating C, et al. Lancet Respir Med. 2025 Mar;13(3):256-271. doi: 10.1016/S2213-2600(24)00411-9. Epub 2025 Jan 2. Lancet Respir Med. 2025. PMID: 39756424 Free PMC article. Clinical Trial.
Carcinoma of the breast.
Grove WR, Fortner CL. Grove WR, et al. Among authors: fortner cl. J Am Pharm Assoc. 1976 May;16(5):254-62. doi: 10.1016/s0003-0465(16)33571-6. J Am Pharm Assoc. 1976. PMID: 774002 Review. No abstract available.
PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report.
Szentpetery S, Riva D, Blumenfeld YJ, Engelhardt JF, Luna-Paredes C, Milla C, Schneider-Futschik EK, Sheffield JS, Darrah R, Davies JC, Flume PA, Foil KE, Fortner CN, Guimbellot JS, Lyerly AD, Mayer-Hamblett N, Ren CL, Spano J, Tillman EM, Trimble A, Wilfond BS, Taylor-Cousar JL. Szentpetery S, et al. Among authors: fortner cn. J Cyst Fibros. 2025 Aug 2:S1569-1993(25)01538-3. doi: 10.1016/j.jcf.2025.07.015. Online ahead of print. J Cyst Fibros. 2025. PMID: 40754574 Free article. Review.
The acute leukemias.
Christian DG, Cornelis WA, Fortner CL. Christian DG, et al. Among authors: fortner cl. J Am Pharm Assoc. 1972 Sep;12(9):473-81. doi: 10.1016/s0003-0465(16)32344-8. J Am Pharm Assoc. 1972. PMID: 5052958 No abstract available.
Hodgkin's disease.
Cornelis WA, Christian DG, Fortner CL. Cornelis WA, et al. Among authors: fortner cl. J Am Pharm Assoc. 1973 Mar;13(3):147-54. doi: 10.1016/s0003-0465(16)32524-1. J Am Pharm Assoc. 1973. PMID: 4689937 No abstract available.
83 results